Schedule 13D ownership disclosure

THESEUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88369M101

Event date: 2021-11-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
43.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-21-001222
Form type
SC 13D/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Nov 18, 2021
Reporting period
Nov 15, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub